Skip to main content
Erschienen in: Pediatric and Developmental Pathology 4/2005

01.08.2005 | Original Article

Pulmonary Interstitial Hemosiderin in Infancy: A Common Consequence of Normal Labor

verfasst von: David M. O. Becroft, John M. D. Thompson, Edwin A. Mitchell

Erschienen in: Pediatric and Developmental Pathology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Deposits of hemosiderin are found frequently in the interstitium of the lungs of infants who die suddenly and have been a suggested marker for hypoxia during previous episodes of apnea. We studied the epidemiology of pulmonary interstitial hemosiderin (PIH) in 94 infants with a diagnosis of the sudden infant death syndrome that was established during the New Zealand Cot Death Study. Twenty-seven infants (29%) had widely distributed PIH. Associations were sought between PIH and variables on which information had been obtained from parental interviews or from medical records. Previous suggestions of associations with increasing birth weight and decreasing age at death were confirmed in multivariate analysis (P = 0.0018 and P = 0.03, respectively) and with increasing gestation in univariate analysis (P < 0.0001). PIH was not found in any of the 13 infants delivered by elective cesarean section compared with a 33% incidence in those exposed to labor (P = 0.02). There was no association with previous apnea. We consider that the likely explanation of these findings is that PIH is a residue of interstitial hemorrhage caused by chest compression during labor that occurs particularly in larger infants of greater gestational age and then clears gradually during early infancy.
Literatur
1.
Zurück zum Zitat Becroft DMO, Lockett BK. Intra-alveolar pulmonary siderophages in sudden infant death: a marker for previous imposed suffocation. Pathology 1997;29:60–63CrossRefPubMed Becroft DMO, Lockett BK. Intra-alveolar pulmonary siderophages in sudden infant death: a marker for previous imposed suffocation. Pathology 1997;29:60–63CrossRefPubMed
2.
Zurück zum Zitat Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants—Cleveland, Ohio, 1963–1996. MMWR 2000;49:180–184 Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants—Cleveland, Ohio, 1963–1996. MMWR 2000;49:180–184
3.
Zurück zum Zitat Stewart S, Fawcett J, Jacobsen W. Interstitial haemosiderin in the lungs of sudden infant death syndrome: a histological hallmark of “near-miss” episodes? J Pathol 1985;145:53–58CrossRefPubMed Stewart S, Fawcett J, Jacobsen W. Interstitial haemosiderin in the lungs of sudden infant death syndrome: a histological hallmark of “near-miss” episodes? J Pathol 1985;145:53–58CrossRefPubMed
4.
Zurück zum Zitat Krous HF, Floyd CW, Nadeau JM, Silva PD, Blackbourne BD, Langston C. Medial smooth muscle thickness in small pulmonary arteries in sudden infant death syndrome revisited. Pediatr Dev Pathol 2002;5:375–385CrossRefPubMed Krous HF, Floyd CW, Nadeau JM, Silva PD, Blackbourne BD, Langston C. Medial smooth muscle thickness in small pulmonary arteries in sudden infant death syndrome revisited. Pediatr Dev Pathol 2002;5:375–385CrossRefPubMed
5.
Zurück zum Zitat Mitchell EA, Thompson JMD. Parental reported apnoea, admissions to hospital and sudden infant death syndrome. Acta Paediatr 2001;90:417–422CrossRefPubMed Mitchell EA, Thompson JMD. Parental reported apnoea, admissions to hospital and sudden infant death syndrome. Acta Paediatr 2001;90:417–422CrossRefPubMed
6.
Zurück zum Zitat Mitchell EA, Scragg R, Stewart AW, Becroft BMO, Taylor BJ, Ford RPK, et al. Results from the first year of the New Zealand Cot Death Study. N Z Med J 1991;104:71–76PubMed Mitchell EA, Scragg R, Stewart AW, Becroft BMO, Taylor BJ, Ford RPK, et al. Results from the first year of the New Zealand Cot Death Study. N Z Med J 1991;104:71–76PubMed
7.
Zurück zum Zitat Mitchell EA, Taylor BJ, Ford RPK, Stewart AW, Becroft DMO, Thompson JMD, et al. Four modifiable and other major risk factors for cot death: The New Zealand Study. J Pediatr Child Health 1992;28(suppl):S3–S8 Mitchell EA, Taylor BJ, Ford RPK, Stewart AW, Becroft DMO, Thompson JMD, et al. Four modifiable and other major risk factors for cot death: The New Zealand Study. J Pediatr Child Health 1992;28(suppl):S3–S8
8.
Zurück zum Zitat Beckwith JB. Discussion of terminology and definition of sudden infant death syndrome. In: Bergman AB, Beckwith JB, Ray CG, eds. Sudden Infant Death Syndrome: Proceedings of the Second International Conference on Causes of Sudden Death in Infants. Seattle: University of Washington Press, 1970;14–22 Beckwith JB. Discussion of terminology and definition of sudden infant death syndrome. In: Bergman AB, Beckwith JB, Ray CG, eds. Sudden Infant Death Syndrome: Proceedings of the Second International Conference on Causes of Sudden Death in Infants. Seattle: University of Washington Press, 1970;14–22
9.
Zurück zum Zitat Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a defintional and diagnostic approach. Pediatrics 2004;114:234–238CrossRefPubMed Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a defintional and diagnostic approach. Pediatrics 2004;114:234–238CrossRefPubMed
10.
Zurück zum Zitat Becroft DMO, Thompson JMD, Mitchell EA. Epidemiology of intrathoracic petechial hemorrhages in sudden infant death syndrome. Pediatr Dev Pathol 1998;1:200–209CrossRefPubMed Becroft DMO, Thompson JMD, Mitchell EA. Epidemiology of intrathoracic petechial hemorrhages in sudden infant death syndrome. Pediatr Dev Pathol 1998;1:200–209CrossRefPubMed
11.
Zurück zum Zitat Byard RW, Stewart WA, Telfer S, Beal SM. Assessment of pulmonary and intrathymic hemosiderin deposition in sudden infant death syndrome. Pediatr Pathol Lab Med 1997;17:275–282CrossRefPubMed Byard RW, Stewart WA, Telfer S, Beal SM. Assessment of pulmonary and intrathymic hemosiderin deposition in sudden infant death syndrome. Pediatr Pathol Lab Med 1997;17:275–282CrossRefPubMed
12.
Zurück zum Zitat Emerson MV, Pieramici DJ, Stoessel KM, Berreen JP, Gariano RF. Incidence and rate of disappearance of retinal hemorrhage in newborns. Ophthalmology 2001;108:36–39CrossRefPubMed Emerson MV, Pieramici DJ, Stoessel KM, Berreen JP, Gariano RF. Incidence and rate of disappearance of retinal hemorrhage in newborns. Ophthalmology 2001;108:36–39CrossRefPubMed
13.
Zurück zum Zitat Baum JD, Bulpitt CJ. Retinal and conjunctival haemorrhage in the newborn. Arch Dis Childh 1970;8:344–349 Baum JD, Bulpitt CJ. Retinal and conjunctival haemorrhage in the newborn. Arch Dis Childh 1970;8:344–349
Metadaten
Titel
Pulmonary Interstitial Hemosiderin in Infancy: A Common Consequence of Normal Labor
verfasst von
David M. O. Becroft
John M. D. Thompson
Edwin A. Mitchell
Publikationsdatum
01.08.2005
Erschienen in
Pediatric and Developmental Pathology / Ausgabe 4/2005
Print ISSN: 1093-5266
Elektronische ISSN: 1615-5742
DOI
https://doi.org/10.1007/s10024-005-0033-8

Weitere Artikel der Ausgabe 4/2005

Pediatric and Developmental Pathology 4/2005 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …